FDA, Welch Allyn initiate Class 1 recall of more than 14K defibrillators

Welch Allyn AED 10 Defibrillator. Image Source: Welch Allyn
The FDA and Welch Allyn have notified healthcare professionals and consumers of a nationwide Class I recall of 14,054 automatic external defibrillator (AED) 10 and MRL JumpStart AEDs manufactured between Oct. 3, 2002 and Jan. 25, 2007.

Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the product will cause serious injury or death, according to the FDA.

The devices may experience low energy shock, unexpected device shutdown and/or susceptibility to electromagnetic noise interference which may prevent defibrillation during cardiac arrest and could lead to death, according to the Skaneateles Falls, N.Y.-based company.

This devices are used by emergency or medical personnel, or by others who have completed CPR AED training courses, in treating adults� experiencing a heart attack.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup